Incidence and bone biopsy findings of atypical femoral fractures. (Q50861958)

24 March 2018

title

Incidence and bone biopsy findings of atypical femoral fractures. (English)

1 reference

24 March 2018

author

Hanna Isaksson

3

1 reference

24 March 2018

Mikael J. Turunen

object named as

Mikael J Turunen

4

0 references

author name string

Inari S Tamminen

1

1 reference

24 March 2018

Tero Yli-Kyyny

2

1 reference

24 March 2018

Xiaoyu Tong

5

1 reference

24 March 2018

Jukka S Jurvelin

6

1 reference

24 March 2018

Heikki Kröger

7

1 reference

24 March 2018

publication date

4 April 2013

1 reference

24 March 2018

Journal of Bone and Mineral Metabolism

published in

1 reference

24 March 2018

volume

31

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

585-594

1 reference

24 March 2018

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Severely suppressed bone turnover and atypical skeletal fragility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Severely suppressed bone turnover: a potential complication of alendronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Infrared analysis of bone in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Issues in modern bone histomorphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

FT-IR imaging of native and tissue-engineered bone and cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Spectroscopic characterization of collagen cross-links in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Bone fragility and collagen cross-links.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Altered bone composition in children with vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0448-7

Bone mineral crystal size

21 January 2018

1 reference

12 December 2020

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis

1 reference

12 December 2020

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

1 reference

12 December 2020

10.1007/S00774-013-0448-7

Identifiers

DOI

1 reference

24 March 2018

release_43n2b4wq7zdxlnleoimuj4bz3i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/43n2b4wq7zdxlnleoimuj4bz3i

24 November 2022

mapped directly with Wikidata item

1 reference

24 March 2018